GB201320894D0 - CSF-1 Therapeutics - Google Patents
CSF-1 TherapeuticsInfo
- Publication number
- GB201320894D0 GB201320894D0 GB201320894A GB201320894A GB201320894D0 GB 201320894 D0 GB201320894 D0 GB 201320894D0 GB 201320894 A GB201320894 A GB 201320894A GB 201320894 A GB201320894 A GB 201320894A GB 201320894 D0 GB201320894 D0 GB 201320894D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- csf
- therapeutics
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201320894A GB201320894D0 (en) | 2013-11-27 | 2013-11-27 | CSF-1 Therapeutics |
MX2015011199A MX2015011199A (en) | 2013-02-28 | 2014-02-28 | Csf1 therapeutics. |
EP14711292.4A EP2961421A1 (en) | 2013-02-28 | 2014-02-28 | Csf1 therapeutics |
PCT/GB2014/050595 WO2014132072A1 (en) | 2013-02-28 | 2014-02-28 | Csf1 therapeutics |
CN201480017323.XA CN105142659A (en) | 2013-02-28 | 2014-02-28 | CSF1 therapeutics |
CA2901368A CA2901368A1 (en) | 2013-02-28 | 2014-02-28 | Csf1 therapeutics |
AU2014222509A AU2014222509A1 (en) | 2013-02-28 | 2014-02-28 | CSF1 therapeutics |
BR112015020235A BR112015020235A2 (en) | 2013-02-28 | 2014-02-28 | biologically active fragment of csf-1 protein or a homologue thereof, nucleic acid, fusion protein, isolated nucleic acid, vector, host cell, fusion protein embodiment of the first aspect of the invention, composition, use of a fusion protein , method of treatment for an individual suffering from liver cancer and undergoing surgery, method of treatment for an individual undergoing liver transplant surgery, and, kit |
EA201591501A EA201591501A1 (en) | 2013-02-28 | 2014-02-28 | THERAPEUTIC TOOLS BASED ON CSF-1 |
JP2015559561A JP2016510977A (en) | 2013-02-28 | 2014-02-28 | CSF1 therapeutic agent |
KR1020157026501A KR20150121715A (en) | 2013-02-28 | 2014-02-28 | Csf1 therapeutics |
US14/770,767 US20160040142A1 (en) | 2013-02-28 | 2014-02-28 | Csf1 therapeutics |
US15/699,425 US20180112193A1 (en) | 2013-02-28 | 2017-09-08 | Csf1 therapeutics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201320894A GB201320894D0 (en) | 2013-11-27 | 2013-11-27 | CSF-1 Therapeutics |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201320894D0 true GB201320894D0 (en) | 2014-01-08 |
Family
ID=49918257
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB201320894A Ceased GB201320894D0 (en) | 2013-02-28 | 2013-11-27 | CSF-1 Therapeutics |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201320894D0 (en) |
-
2013
- 2013-11-27 GB GB201320894A patent/GB201320894D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201413149D0 (en) | No details | |
HK1219427A1 (en) | Complex | |
EP2989885A4 (en) | Combine | |
GB201410903D0 (en) | No details | |
GB201506699D0 (en) | No details | |
GB201421649D0 (en) | No details | |
GB201518344D0 (en) | No details present | |
GB201418212D0 (en) | No details | |
HK1219986A1 (en) | Ptd-smad7 therapeutics ptd-smad7 | |
GB201418129D0 (en) | No details | |
GB201421548D0 (en) | No details | |
GB201408089D0 (en) | No details | |
GB201418214D0 (en) | No details | |
GB201416327D0 (en) | No details | |
HK1204451A1 (en) | Novel use | |
GB201407200D0 (en) | No details | |
GB201414328D0 (en) | None | |
GB201417843D0 (en) | No details | |
GB201311130D0 (en) | Greensleeves I | |
GB201500998D0 (en) | No details | |
GB201410951D0 (en) | None | |
GB201320894D0 (en) | CSF-1 Therapeutics | |
GB201303537D0 (en) | CSF-1 based therapeutics | |
GB201303366D0 (en) | CSF-1 based therapeutics | |
GB201300932D0 (en) | Therapeutics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |